CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (USD $)
In Thousands, except Share data, unless otherwise specified |
12 Months Ended | |
---|---|---|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
Income Statement [Abstract] | ||
Grant revenues | $ 9us-gaap_RevenueFromGrants | |
Operating Expenses: | ||
Research and development | 4,071us-gaap_ResearchAndDevelopmentExpense | 3,862us-gaap_ResearchAndDevelopmentExpense |
General and adminstrative | 1,737us-gaap_GeneralAndAdministrativeExpense | 219us-gaap_GeneralAndAdministrativeExpense |
Total Operating Expenses | 5,808us-gaap_OperatingExpenses | 4,081us-gaap_OperatingExpenses |
Loss from operations | (5,799)us-gaap_OperatingIncomeLoss | (4,081)us-gaap_OperatingIncomeLoss |
Interest income | 96us-gaap_InterestIncomeOperating | 2us-gaap_InterestIncomeOperating |
Realized gain on sale of marketable securities | 1,359us-gaap_RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments | |
Other expense | (7)us-gaap_OtherExpenses | |
Fair value of warrant liabilities in excess of proceeds from financing | (946)us-gaap_FairValueAdjustmentOfWarrants | |
Loss on return of escrowed shares | (584)us-gaap_GainLossOnDispositionOfAssets | |
Change in fair market value of derivative liability | 5,730us-gaap_GainLossOnDerivativeInstrumentsNetPretax | 192us-gaap_GainLossOnDerivativeInstrumentsNetPretax |
Total other income, net | 5,648us-gaap_OtherNonoperatingIncomeExpense | 194us-gaap_OtherNonoperatingIncomeExpense |
Loss before income taxes | (151)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | (3,887)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
Income tax benefit | 52us-gaap_IncomeTaxExpenseBenefit | |
Net loss | (99)us-gaap_NetIncomeLoss | (3,887)us-gaap_NetIncomeLoss |
Net loss | (99)us-gaap_NetIncomeLoss | (3,887)us-gaap_NetIncomeLoss |
Unrealized gain on marketable securities, net of tax | 236us-gaap_MarketableSecuritiesUnrealizedGainLoss | |
Total comprehensive income (loss) | $ 137us-gaap_ComprehensiveIncomeNetOfTax | $ (3,887)us-gaap_ComprehensiveIncomeNetOfTax |
Net loss per common share: | ||
Net loss per share, basic | $ 0.0us-gaap_EarningsPerShareBasic | $ (0.07)us-gaap_EarningsPerShareBasic |
Net loss per share, diluted | $ (0.01)us-gaap_EarningsPerShareDiluted | $ (0.07)us-gaap_EarningsPerShareDiluted |
Weighted average common shares outstanding, basic | 326,799us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 57,255us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
Weighted average common shares outstanding, diluted | 327,753us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 57,255us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
X | ||||||||||
- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate net change in the difference between the fair value and the carrying value, or in the comparative fair values, of marketable securities categorized as trading held at each balance sheet date, that was included in earnings for the period, which may have arisen from (a) securities classified as trading, (b) the unrealized holding gain (loss) on held-to-maturity securities transferred to the trading security category, and (c) the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) on available-for-sale securities transferred to trading securities during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
X | ||||||||||
- Definition
This element represents a sum total of expenses not separately reflected on the income statement for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This item represents the total realized gain (loss) included in earnings for the period as a result of selling marketable securities categorized as trading, available-for-sale, or held-to-maturity and any gains or losses realized during the period from the sale of investments accounted for under the cost method of accounting and/or investments that are separately or otherwise not categorized as trading, available-for-sale, or held-to-maturity. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities. No definition available.
|
X | ||||||||||
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|